Pharmaceuticals

Europe Infectious Diseases: Country Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities-France, Germany, Italy, Spain, UK

  • VPG695287
  • 1600 Pages
  • September 2016
  • Pharmaceuticals

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.

VPGMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, market segment, and country; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive five-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Coverage

France, Germany, Italy, Spain, UK

Market Segmentation Analysis

- Sales and market shares of major suppliers
by individual test and country.

- Volume and sales forecasts for over 100 infectious disease
assays by country, individual test and market segment:

Hospitals
Blood Banks
Commercial/Private Laboratories
Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
culture/microscopy).

- Review of the market dynamics, trends,
structure, size, growth and major suppliers
by country.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for infectious disease testing.

- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Contains 1,600 pages and 580 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Hemophilia Treatment Market (Type, Medicine and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Hemophilia is a hereditary genetic disorder which impairs body ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Lung Cancer Therapeutics Market (Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Lung cancer is a malignant lung carcinoma that is characterized by abnormal cell growth in lung tissue. As the tumor grows in size, it decreases the lungs ability to provide ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Hormone Refractory Breast Cancer Asia-Pacific Market Research Report, 2013 - 2020

Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Injectable Drug Delivery Market (Formulation, Device, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Injectable drug delivery system is infusion method, which administers drug into body by piercing the skin with the help of syringe attached to the needle. Most popular route it follows ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemoglobinopathies Market (Pipeline Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Neuroprotective Products Market (Class of Drugs, Treatment of Medical Conditions and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>